These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 8003612)

  • 41. Detection of adrenocortical autoantibodies in Addison's disease with a peroxidase-labelled protein A technique.
    Silva RC; Faiçal S; Laureti S; Falorni A; Dib SA; Kater CE
    Braz J Med Biol Res; 1998 Sep; 31(9):1141-8. PubMed ID: 9876281
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [21-hydroxylase autoantibodies as a marker of adrenal involvement in patients with autoimmune endocrinopathies].
    Degros V; Pons L; Ghulam A; Racadot A
    Ann Biol Clin (Paris); 1999; 57(6):705-9. PubMed ID: 10572219
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Addison's disease: a survey on 633 patients in Padova.
    Betterle C; Scarpa R; Garelli S; Morlin L; Lazzarotto F; Presotto F; Coco G; Masiero S; Parolo A; Albergoni MP; Favero R; Barollo S; Salvà M; Basso D; Chen S; Rees Smith B; Furmaniak J; Mantero F
    Eur J Endocrinol; 2013 Dec; 169(6):773-84. PubMed ID: 24014553
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The effect of types I and III interferons on adrenocortical cells and its possible implications for autoimmune Addison's disease.
    Hellesen A; Edvardsen K; Breivik L; Husebye ES; Bratland E
    Clin Exp Immunol; 2014 Jun; 176(3):351-62. PubMed ID: 24666275
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Italian addison network study: update of diagnostic criteria for the etiological classification of primary adrenal insufficiency.
    Falorni A; Laureti S; De Bellis A; Zanchetta R; Tiberti C; Arnaldi G; Bini V; Beck-Peccoz P; Bizzarro A; Dotta F; Mantero F; Bellastella A; Betterle C; Santeusanio F;
    J Clin Endocrinol Metab; 2004 Apr; 89(4):1598-604. PubMed ID: 15070918
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Remission of subclinical adrenocortical failure in subjects with adrenal autoantibodies.
    De Bellis A; Bizzarro A; Rossi R; Paglionico VA; Criscuolo T; Lombardi G; Bellastella A
    J Clin Endocrinol Metab; 1993 Apr; 76(4):1002-7. PubMed ID: 8473373
    [TBL] [Abstract][Full Text] [Related]  

  • 47. T and B cell reactivity to adrenal antigens in autoimmune Addison's disease.
    Freeman M; Weetman AP
    Clin Exp Immunol; 1992 May; 88(2):275-9. PubMed ID: 1572092
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Induction of CXCL10 chemokine in adrenocortical cells by stimulation through toll-like receptor 3.
    Bratland E; Hellesen A; Husebye ES
    Mol Cell Endocrinol; 2013 Jan; 365(1):75-83. PubMed ID: 22989785
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cytochrome P450 1A2 is a hepatic autoantigen in autoimmune polyglandular syndrome type 1.
    Clemente MG; Obermayer-Straub P; Meloni A; Strassburg CP; Arangino V; Tukey RH; De Virgiliis S; Manns MP
    J Clin Endocrinol Metab; 1997 May; 82(5):1353-61. PubMed ID: 9141515
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Rare occurrence of Addison's disease and diabetes mellitus in children.
    Bakdoud Z; Fraser E; Glover L; Lawson WG; Fiser RH; Eders MJ
    South Med J; 1977 Jun; 70(6):713-5. PubMed ID: 195345
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Decreased expression of cyclic adenosine monophosphate-regulated aldose reductase (AKR1B1) is associated with malignancy in human sporadic adrenocortical tumors.
    Lefrançois-Martinez AM; Bertherat J; Val P; Tournaire C; Gallo-Payet N; Hyndman D; Veyssière G; Bertagna X; Jean C; Martinez A
    J Clin Endocrinol Metab; 2004 Jun; 89(6):3010-9. PubMed ID: 15181092
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Regulation of steroidogenesis in NCI-H295 cells: a cellular model of the human fetal adrenal.
    Staels B; Hum DW; Miller WL
    Mol Endocrinol; 1993 Mar; 7(3):423-33. PubMed ID: 8387159
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Analysis of autoantibody epitopes on steroid 21-hydroxylase using a panel of monoclonal antibodies.
    Chen S; Sawicka J; Prentice L; Sanders JF; Tanaka H; Petersen V; Betterle C; Volpato M; Roberts S; Powell M; Smith BR; Furmaniak J
    J Clin Endocrinol Metab; 1998 Aug; 83(8):2977-86. PubMed ID: 9709979
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The NCI-H295 cell line: a pluripotent model for human adrenocortical studies.
    Rainey WE; Bird IM; Mason JI
    Mol Cell Endocrinol; 1994 Apr; 100(1-2):45-50. PubMed ID: 8056157
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Radioimmunologic determination of pituitary autoantibodies in patients with Addison's disease].
    Gryczyńska M; Kosowicz J
    Endokrynol Pol; 1991; 42(4):561-6. PubMed ID: 1364507
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Diagnosis and classification of Addison's disease (autoimmune adrenalitis).
    Brandão Neto RA; de Carvalho JF
    Autoimmun Rev; 2014; 13(4-5):408-11. PubMed ID: 24424183
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Autoimmune Addison's disease. Analysis of autoantibody binding sites on human steroid 21-hydroxylase.
    Wedlock N; Asawa T; Baumann-Antczak A; Smith BR; Furmaniak J
    FEBS Lett; 1993 Oct; 332(1-2):123-6. PubMed ID: 8405426
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Familial occurrence of Addison's disease].
    Korczowski R; Nizankowska-Błaz T; Watróbska S
    Pol Tyg Lek; 1985 Apr; 40(16):467-8. PubMed ID: 4011498
    [No Abstract]   [Full Text] [Related]  

  • 59. Transcription factor 3',5'-cyclic adenosine 5'-monophosphate-responsive element-binding protein (CREB) is decreased during human adrenal cortex tumorigenesis and fetal development.
    Rosenberg D; Groussin L; Jullian E; Perlemoine K; Medjane S; Louvel A; Bertagna X; Bertherat J
    J Clin Endocrinol Metab; 2003 Aug; 88(8):3958-65. PubMed ID: 12915693
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Immunological studies in the neonate of a mother with Addison's disease and diabetes mellitus.
    Gamlen TR; Aynsley-Green A; Irvine WJ; McCallum CJ
    Clin Exp Immunol; 1977 Apr; 28(1):192-5. PubMed ID: 324676
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.